Biofunctionalization with a TGFβ-1 Inhibitor Peptide in the Osseointegration of Synthetic Bone Grafts: An In Vivo Study in Beagle Dogs
MetadataShow full item record
AuthorCirera, Andrea; Manzanares, María Cristina; Sevilla, Pablo; Ortiz Hernández, Mónica; Galindo Moreno, Pablo Antonio; Gil, Javier
OsseointegrationBiofunctionalizationHistomorphometrical analysisScanning electron microscopySynthetic bone graftTGFbeta- 1
Cirera, A., Manzanares, M. C., Sevilla, P., Ortiz-Hernandez, M., Galindo-Moreno, P., & Gil, J. (2019). Biofunctionalization with a TGFβ-1 inhibitor peptide in the osseointegration of synthetic bone grafts: an in vivo study in beagle dogs. Materials, 12(19), 3168.
SponsorshipThe present study was supported entirely by the Research Cathedra Klockner-University of Granada.
Objectives: The aim of this research was to determine the osseointegration of two presentations of biphasic calcium phosphate (BCP) biomaterial—one untreated and another submitted to biofunctionalization with a TGF- 1 inhibitor peptide, P144, on dental alveolus. The biofunctionalization of the biomaterial’s granules maintains a stable membranous bone formation throughout the experiment timeline, benefitting from the constant presence of vascular structures in the alveolar space, in a more active manner that in the control samples. Better results in the experimental groups were proven both by quantitative and qualitative analysis. Synthetic bone graft biofunctionalization results in slightly better quantitative parameters of the implant’s osseointegration. The qualitative histological and ultramicroscopic analysis shows that biofunctionalization may shorten the healing period of dental biomaterials.